S&P 5005,963+0.54%
NASDAQ21,443+0.87%
DOW43,892+0.31%
DAX23,888+0.44%
FTSE 1008,721-0.12%
EUR/USD1.1465+0.07%
GBP/USD1.3220+0.14%
USD/JPY161.31-0.03%
Gold3,241+0.22%
WTI Oil76.40+0.81%
Bitcoin103,241+1.43%
10Y UST4.47%-9bp
S&P 5005,963+0.54%
NASDAQ21,443+0.87%
DOW43,892+0.31%
DAX23,888+0.44%
FTSE 1008,721-0.12%
EUR/USD1.1465+0.07%
GBP/USD1.3220+0.14%
USD/JPY161.31-0.03%
Gold3,241+0.22%
WTI Oil76.40+0.81%
Bitcoin103,241+1.43%
10Y UST4.47%-9bp
MarketsFN
Home/Hedge Fund/RTW Investments/Q1 2021

RTW Investments

Periodo: Q1 2021 Β· Depositato: 2021-05-14
Vedi su SEC EDGAR β†—
AUM
$6.41B
Valore totale del portafoglio
Posizioni
111
Titoli dichiarati
Prima Posizione
RCKT
10.9% $697.3M
Var. Trimestrali
+8 / -8
nuovi Β· usciti
⚠️Informativa sui Depositi 13F

I dati AUM mostrati sono calcolati sommando il valore di mercato dichiarato di tutte le posizioni nei depositi SEC 13F-HR β€” non rappresentano il patrimonio effettivo gestito dal fondo.

  • Escluse liquiditΓ , obbligazioni, private equity, posizioni corte e azioni estere non soggette all'obbligo di dichiarazione.
  • Per le opzioni PUT e CALL, il Valore dichiarato Γ¨ il valore nozionale delle azioni sottostanti β€” non il premio pagato. CiΓ² sovrastima significativamente il capitale effettivamente a rischio.
  • Il patrimonio reale del fondo Γ¨ tipicamente superiore e include strategie, strumenti e posizioni che non compaiono mai in un 13F.
  • I depositi 13F riguardano i gestori istituzionali con β‰₯$100M in titoli 13F. Le posizioni riflettono le partecipazioni a fine trimestre, divulgate entro 45 giorni dalla fine del periodo.

Dati provenienti da SEC EDGAR. Questo tracker Γ¨ a scopo puramente informativo e non costituisce consulenza finanziaria.

Partecipazioni in Portafoglio

Prime 30 posizioni

⚠️ Performance % calcolata dalla data di deposito ( 2021-05-14) si riferisce al titolo sottostante β€” non al P&L del derivato.
TickerEmittenteNozionalePortafoglio %Al DepositoOra (Fine Giornata)Dal DepositoAllocazione
RCKTRocket Pharmaceuticals Inc$697.3M10.89%$44.37$3.84-91.3%
10.9%
SPYSPDR S&P 500 ETF TR$375.0M5.85%$369.21$744.78+101.7%
5.8%
VCELVericel Corp$250.9M3.92%$55.55$46.98-15.4%
3.9%
PTCTPTC Therapeutics Inc$250.7M3.91%$47.35$83.31+76.0%
3.9%
ALNYAlnylam Pharmaceuticals Inc$237.7M3.71%$141.19$312.78+121.5%
3.7%
MRTXMirati Therapeutics Inc$228.4M3.57%β€”β€”
3.6%
DRNADicerna Pharmaceuticals Inc$190.8M2.98%β€”β€”
3.0%
ILMNIllumina Inc$185.1M2.89%$373.60$188.68-49.5%
2.9%
NTRANatera Inc$173.9M2.71%$101.54$279.32+175.1%
2.7%
DMTKQDermTech Inc$158.4M2.47%β€”β€”
2.5%
ESTAEstablishment Labs Hldgs Inc$145.0M2.26%$62.53$89.25+42.7%
2.3%
STOKStoke Therapeutics Inc$141.5M2.21%$38.84$32.70-15.8%
2.2%
MASIMasimo Corp$136.6M2.13%$229.66β€”
2.1%
TXG10x Genomics Inc$128.8M2.01%$181.00$39.01-78.5%
2.0%
CERNCerner Corp$127.5M1.99%β€”β€”
2.0%
AXNXAxonics Modulation Technolog$112.8M1.76%β€”β€”
1.8%
QDELXXXXQuidel Corp$112.4M1.75%β€”β€”
1.8%
ARVNArvinas Inc$107.3M1.67%$66.10$8.39-87.3%
1.7%
GMEDGlobus Med Inc$103.0M1.61%$61.67$80.12+29.9%
1.6%
IMVTImmunovant Inc$102.0M1.59%$16.04$38.79+141.8%
1.6%
TNDMTandem Diabetes Care Inc$100.5M1.57%$88.25$15.32-82.6%
1.6%
ITOSIteos Therapeutics Inc$94.4M1.47%β€”β€”
1.5%
GHGuardant Health Inc$93.1M1.45%$152.65$167.98+10.0%
1.4%
AXSMAxsome Therapeutics Inc$91.5M1.43%$56.62$244.31+331.5%
1.4%
PTGXProtagonist Therapeutics Inc$90.8M1.42%$25.90$131.62+408.2%
1.4%
RNAMAvidity Biosciences Inc$87.1M1.36%β€”β€”
1.4%
CLDXCelldex Therapeutics Inc New$80.5M1.26%$20.60$38.37+86.3%
1.3%
CCCCC4 Therapeutics Inc$79.4M1.24%$36.99$4.30-88.4%
1.2%
TARSTarsus Pharmaceuticals Inc.$79.1M1.23%$32.23$65.44+103.0%
1.2%
ADVMAdverum Biotechnologies Inc$72.5M1.13%β€”β€”
1.1%

AttivitΓ  Trimestre su Trimestre

Q1 2021 vs. Q4 2020

Nuove Posizioni (8)

TickerEmittenteNozionaleDal Deposito
SPYSPDR S&P 500 ETF TR$375.0M+101.7%
QDELXXXXQuidel Corp$112.4M
RXDXPrometheus Biosciences Inc$51.7M
IMCRImmunocore Hldgs PLC$50.1M
GTHGenetron Hldgs Ltd$39.0M
LABPLandos Biopharma Inc$38.3M
ASLNAslan Pharmaceuticals Ltd$10.9M
CHAQChardan Healthcr Acqstn 2 Co$8.4M

Posizioni Chiuse (8)

TickerEmittenteNozionale
FREQFrequency Therapeutics Inc$86.8M
FPRXFive Prime Therapeutics Inc$42.8M
PENPenumbra Inc$20.7M
ODTCOdonate Therapeutics Inc$19.2M
GNMKGenMark Diagnostics Inc$11.1M
PHGEBiomx Inc$3.8M
PANAUPanacea Acquisition Corp$3.8M
OSUROraSure Technologies Inc$1.9M

Aumentate (8)

TickerEmittenteNozionaleVar. AzioniDal Deposito
ITOSIteos Therapeutics Inc$58.5M+157.2%
TNDMTandem Diabetes Care Inc$37.3M+72.4%-82.6%
MGNXMacroGenics Inc$35.4M+60.3%
FULCFulcrum Therapeutics Inc$13.5M+54.7%
RGNXRegenxbio Inc$1.4M+47.6%
TBIOTranslate Bio Inc$17.4M+47.1%
BWAYBrainsway Ltd$6.2M+45.2%
IDYAIdeaya Biosciences Inc$32.1M+33.5%

Ridotte (8)

TickerEmittenteNozionaleVar. AzioniDal Deposito
KURAKura Oncology Inc$-25.0M-36.4%
CELLBerkeley Lts Inc$-16.1M-20.7%
IMVTImmunovant Inc$-248.7M-16.3%+141.8%
ARVNArvinas Inc$-44.8M-9.4%-87.3%
RCKTRocket Pharmaceuticals Inc$-238.3M-7.9%-91.3%
BLUBellus Health Inc New$3.3M-4.3%
PTGXProtagonist Therapeutics Inc$17.3M-3.9%+408.2%
Trillium Therapeutics Inc$-9.4M-3.4%
← Torna agli Hedge Fund